Insider · CIK 0001909362

Aslan Fred

Reports to the SEC for 1 company · SAN DIEGO, CA

sec.gov

Transactions

Companies

Filings

CIK

0001909362

Forms 4 and 5

Insider transactions

28 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2026-10-06	ARTVArtiva Biotherapeutics, Inc.S Sale	Director, Chief Executive Officer	SSale	−23.5K sh	$7.20	−$169K	1,519,606
2026-10-05	ARTVArtiva Biotherapeutics, Inc.S Sale	Director, Chief Executive Officer	SSale	−61.7K sh	$6.84	−$422K	1,543,069
2026-09-15	ARTVArtiva Biotherapeutics, Inc.A Award	Director, Chief Executive Officer	AAward	+110K sh	—	—	1,604,765
2026-09-15	ARTVArtiva Biotherapeutics, Inc. · Employee Stock Option (Right to Buy)A Award	Director, Chief Executive Officer	AAward	+315K sh	—	—	315,000
2026-09-10	ARTVArtiva Biotherapeutics, Inc.A Award	Director, Chief Executive Officer	AAward	+45K sh	—	—	1,494,765
2026-09-10	ARTVArtiva Biotherapeutics, Inc. · Employee Stock Option (Right to Buy)A Award	Director, Chief Executive Officer	AAward	+155K sh	—	—	155,000
2026-09-08	ARTVArtiva Biotherapeutics, Inc.S Sale	Director, Chief Executive Officer	SSale	−23.4K sh	$10.92	−$256K	1,449,765
2026-09-03	ARTVArtiva Biotherapeutics, Inc.S Sale	Director, Chief Executive Officer	SSale	−61.9K sh	$11.16	−$690K	1,473,194
2026-05-19	ARTVArtiva Biotherapeutics, Inc.S Sale	Director, Chief Executive Officer	SSale	−27.1K sh	$9.01	−$244K	1,535,082
2026-02-15	ARTVArtiva Biotherapeutics, Inc.F Tax Payment	Director, Chief Executive Officer	FTax Payment	−14.6K sh	$4.00	−$58.4K	1,562,198
2026-02-15	ARTVArtiva Biotherapeutics, Inc.A Award	Director, Chief Executive Officer	AAward	+367K sh	—	—	1,576,798
2025-12-15	ARTVArtiva Biotherapeutics, Inc.S Sale	Director, Chief Executive Officer	SSale	−3,187 sh	$6.00	−$19.1K	1,209,948
2025-12-12	ARTVArtiva Biotherapeutics, Inc. · Employee Stock Option (Right to Buy)D Disposition to Issuer	Director, Chief Executive Officer	DDisposition to Issuer	−114K sh	—	—	0
2025-12-12	ARTVArtiva Biotherapeutics, Inc. · Employee Stock Option (Right to Buy)D Disposition to Issuer	Director, Chief Executive Officer	DDisposition to Issuer	−26.5K sh	—	—	0
2025-12-12	ARTVArtiva Biotherapeutics, Inc. · Employee Stock Option (Right to Buy)D Disposition to Issuer	Director, Chief Executive Officer	DDisposition to Issuer	−319K sh	—	—	0
2025-12-12	ARTVArtiva Biotherapeutics, Inc.A Award	Director, Chief Executive Officer	AAward	+869K sh	—	—	1,213,135
2025-12-12	ARTVArtiva Biotherapeutics, Inc. · Employee Stock Option (Right to Buy)D Disposition to Issuer	Director, Chief Executive Officer	DDisposition to Issuer	−101K sh	—	—	0
2025-12-12	ARTVArtiva Biotherapeutics, Inc. · Employee Stock Option (Right to Buy)D Disposition to Issuer	Director, Chief Executive Officer	DDisposition to Issuer	−51.5K sh	—	—	0
2025-12-12	ARTVArtiva Biotherapeutics, Inc. · Employee Stock Option (Right to Buy)D Disposition to Issuer	Director, Chief Executive Officer	DDisposition to Issuer	−257K sh	—	—	0
2025-11-17	ARTVArtiva Biotherapeutics, Inc.S Sale	Director, Chief Executive Officer	SSale	−6,375 sh	$3.38	−$21.5K	343,999
2025-11-15	ARTVArtiva Biotherapeutics, Inc.F Tax Payment	Director, Chief Executive Officer	FTax Payment	−6,347 sh	$3.25	−$20.6K	350,374
2025-10-17	ARTVArtiva Biotherapeutics, Inc.S Sale	Director, Chief Executive Officer	SSale	−25.5K sh	$6.00	−$153K	356,721
2025-08-15	ARTVArtiva Biotherapeutics, Inc.S Sale	Director, Chief Executive Officer	SSale	−25.5K sh	$2.73	−$69.6K	386,693
2025-08-15	ARTVArtiva Biotherapeutics, Inc.F Tax Payment	Director, Chief Executive Officer	FTax Payment	−4,472 sh	$2.75	−$12.3K	382,221
2025-05-15	ARTVArtiva Biotherapeutics, Inc.F Tax Payment	Director, Chief Executive Officer	FTax Payment	−4,472 sh	$2.13	−$9,525.36	412,193
2025-03-05	ARTVArtiva Biotherapeutics, Inc.A Award	Director, Chief Executive Officer	AAward	+200K sh	—	—	416,665
2024-07-22	ARTVArtiva Biotherapeutics, Inc.A Award	Director, Chief Executive Officer	AAward	+229K sh	—	—	228,905
2024-07-18	ARTVArtiva Biotherapeutics, Inc. · Employee Stock Option (Right to Buy)A Award	Director, Chief Executive Officer	AAward	+344K sh	—	—	343,811

Recent filings

Accepted (ET)
Oct 74
Aslan Fred0001193125-26-416953
SEC(opens sec.gov)
Oct 64
Aslan Fred0001193125-26-415527
SEC(opens sec.gov)
Sep 154
Aslan Fred0001193125-26-392025
SEC(opens sec.gov)
Sep 144
Aslan Fred0001193125-26-391012
SEC(opens sec.gov)
Sep 94
Aslan Fred0001193125-26-386431
SEC(opens sec.gov)
Sep 44
Aslan Fred0001193125-26-383618
SEC(opens sec.gov)
May 194
Aslan Fred0001193125-26-231506
SEC(opens sec.gov)
Feb 184
Aslan Fred0001193125-26-057667
SEC(opens sec.gov)
Dec 154
Aslan Fred0001193125-25-319696
SEC(opens sec.gov)
Dec 124
Aslan Fred0001193125-25-317980
SEC(opens sec.gov)
Nov 174
Aslan Fred0001193125-25-285004
SEC(opens sec.gov)

Companies

Artiva Biotherapeutics, Inc.Director, Chief Executive OfficerARTV

Address

C/O ARTIVA BIOTHERAPEUTICS, INC. 5505 MOREHOUSE DRIVE, SUITE 100

SAN DIEGO, CA, 92121